RaicheTPammettRDattaniS, et al. Community pharmacists’ evolving role in Canadian primary health care: a vision of harmonization in a patchwork system. Pharm Pract (Granada)2020;18:2171. doi:10.18549/PharmPract.2020.4.2171
2.
BooneCGBishopACIversNDesveauxLTadrousM.Audit and feedback in community pharmacy: an untapped strategy of quality improvement. Can Pharm J (Ott)2022;155:79-81. doi:10.1177/17151635211056528
3.
AlhuseinNWatsonMC.Quality indicators and community pharmacy services: a scoping review. Int J Pharm Pract2019;27:490-500. doi:10.1111/ijpp.12561
4.
NundySCooperLAMateKS.The quintuple aim for health care improvement: a new imperative to advance health equity. JAMA2022;327:521-2. doi:10.1001/jama.2021.25181
5.
ReisLGregórioJ.Professional pharmacy services’ outcomes performance measurement: a narrative review. Explor Res Clin Soc Pharm2024;16:100533. doi:10.1016/j.rcsop.2024.100533
6.
BrookRHMcGlynnEAClearyPD.Quality of health care: part 2: measuring quality of care. N Engl J Med1996;335:966-70.
7.
IversNYogasingamSLacroixM, et al. Audit and feedback: effects on professional practice. Cochrane Database Syst Rev2025;3(3):CD000259. doi:10.1002/14651858.CD000259.pub4
8.
DoucetteWRConklinMMottDANewlandBPlakeKSNauDP.Pharmacy Quality Alliance: five phase I demonstration projects: descriptions and lessons learned. J Am Pharm Assoc (2003) 2011;51:544-0. doi:10.1331/JAPhA.2011.10100
9.
TorabiAChuCAbdul AzizY, et al. Evaluating regional and temporal variations in quality indicators for opioid initiation and pharmacist medication reviews in Ontario: a population-based repeated cross-sectional study. Can Pharm J (Ott)2025;158(5):294-301. doi:10.1177/17151635251358873.
10.
Health Quality Alberta. Alberta quality dimensions for health. Calgary (AB): Health Quality Alberta; 2025.
11.
Ontario Health. Quality improvement plans. Toronto (ON): Ontario Health; 2025.
12.
HatahEBraundRTordoffJDuffullSB.A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. Br J Clin Pharmacol2014;77:102-15.
13.
HuiskesVJBBurgerDMVan Den EndeCHMvan den BemtBJ. Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials. BMC Fam Pract2017;18:5.
14.
Al Hamarneh YazidNTsuyuki RossT. The impact of point of care testing in patients with diabetes receiving a medication review. In: International Pharmaceutical Federation Congress; Copenhagen, Denmark; 2025.
15.
LiuSTsuyukiRTGrahamMMNelsonDSemeniukGAl HamarnehYN.Implementation of pharmacist case-finding and care pathway intervention for vascular prevention (PRxOACT): protocol for a randomized controlled trial. CJC Open2025;7:821-31. doi:10.1016/j.cjco.2025.03.011
16.
GershonASMecredyGCAaronSD, et al. Development of quality indicators for chronic obstructive pulmonary disease (COPD): a modified RAND appropriateness method. Can J Respir Crit Care Sleep Med2019;3:30-8.
Ontario Health. Chronic obstructive pulmonary disease: care in the community for adults. Toronto (ON): Ontario Health; 2018.
19.
RutkowskiS.Management challenges in chronic obstructive pulmonary disease in the COVID-19 pandemic: telehealth and virtual reality. J Clin Med2021;10:1261.
20.
Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes2018;42:S1-325.
21.
Ontario Health. Prediabetes and type 2 diabetes care for people of all ages. Toronto (ON): Ontario Health; 2021.
22.
Ontario Health. Care for adults with osteoarthritis of the knee, hip, hand, or shoulder. Toronto (ON): Ontario Health; 2024.
23.
BurgeFIBowerKPutnamWCoxJL.Quality indicators for cardiovascular primary care. Can J Cardiol2007;23:383-8.
24.
LeeDSTranCFlintoftV, et al. CCORT/CCS quality indicators for congestive heart failure care. Can J Cardiol2003;19:357-64.
25.
BamKOlaiyaMTCadilhacDA, et al. Quality indicators for the primary prevention of cardiovascular disease in primary care: a systematic review. PLoS One2024;19:e0312137.
